|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/713 | |
| C07C 229/12 | |||
| C12N 15/113 | |||
| C12N 15/88 | |||
| A61K 39/00 | |||
| A61K 47/44 |
| (11) | Number of the document | 2575764 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11726579.3 |
| Date of filing the European patent application | 2011-06-03 | |
| (97) | Date of publication of the European application | 2013-04-10 |
| (45) | Date of publication and mention of the grant of the patent | 2017-04-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/039164 |
| Date | 2011-06-03 |
| (87) | Number | WO 2011/153493 |
| Date | 2011-12-08 |
| (30) | Number | Date | Country code |
| 201161489197 P | 2011-05-23 | US | |
| 351146 P | 2010-06-03 | US |
| (72) |
MANOHARAN, Muthiah, US
MAIER, Martin, US
JAYARAMAN, Muthusamy, US
MATSUDA, Shigeo, US
JAYAPRAKASH, Narayanannair, K., US
RAJEEV, Kallanthottathil, G., US
AKINC, Akin, US
BAILLIE, Thomas, A., US
|
| (73) |
Alnylam Pharmaceuticals, Inc.,
300 Third Street, Cambridge, MA 02142,
US
|
| (54) | BIODEGRADABLE LIPIDS FOR THE DELIVERY OF ACTIVE AGENTS |
| BIODEGRADABLE LIPIDS FOR THE DELIVERY OF ACTIVE AGENTS |